EG16563A - Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones - Google Patents
Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinedionesInfo
- Publication number
- EG16563A EG16563A EG32/84A EG3284A EG16563A EG 16563 A EG16563 A EG 16563A EG 32/84 A EG32/84 A EG 32/84A EG 3284 A EG3284 A EG 3284A EG 16563 A EG16563 A EG 16563A
- Authority
- EG
- Egypt
- Prior art keywords
- alkoxyphenyl
- thiazolidinediones
- aldose reductase
- reductase inhibiting
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Paints Or Removers (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45868483A | 1983-01-17 | 1983-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG16563A true EG16563A (en) | 1989-06-30 |
Family
ID=23821708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG32/84A EG16563A (en) | 1983-01-17 | 1984-01-17 | Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0117035B1 (da) |
| JP (1) | JPS59137474A (da) |
| KR (1) | KR870001267B1 (da) |
| AT (1) | ATE45574T1 (da) |
| AU (1) | AU539921B2 (da) |
| CA (1) | CA1233470A (da) |
| CS (1) | CS241149B2 (da) |
| DD (1) | DD216012A5 (da) |
| DE (1) | DE3479419D1 (da) |
| DK (1) | DK17984A (da) |
| EG (1) | EG16563A (da) |
| ES (1) | ES528887A0 (da) |
| FI (1) | FI840155A (da) |
| GR (1) | GR79763B (da) |
| GT (1) | GT198400006A (da) |
| HU (1) | HU191265B (da) |
| IE (1) | IE56842B1 (da) |
| IL (1) | IL70690A (da) |
| NO (1) | NO162462C (da) |
| NZ (1) | NZ206845A (da) |
| PH (1) | PH18882A (da) |
| PL (1) | PL142152B1 (da) |
| PT (1) | PT77958B (da) |
| SU (1) | SU1189341A3 (da) |
| YU (1) | YU43336B (da) |
| ZA (1) | ZA84305B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU210339B (en) | 1985-05-21 | 1995-03-28 | Pfizer | Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect |
| GB8910639D0 (en) * | 1989-05-09 | 1989-06-21 | Beecham Group Plc | Novel compounds |
| JPH04210683A (ja) * | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
| JP3053490B2 (ja) * | 1991-02-25 | 2000-06-19 | 杏林製薬株式会社 | チアゾリジン−２，４−ジオン誘導体とその塩及び製造法 |
| EP4273132A3 (en) * | 2017-03-03 | 2024-01-10 | Gilead Sciences, Inc. | Processes for preparing acc inhibitors and solid forms thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2263296A1 (de) * | 1972-12-23 | 1974-06-27 | Bayer Ag | 4-alkyl-thiazol-2-one, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| AU6610081A (en) * | 1980-01-24 | 1981-07-30 | Senju Pharmaceutical Co., Ltd. | Thiazolidine derivatives |
| JPS56104876A (en) * | 1980-01-24 | 1981-08-20 | Takeda Chem Ind Ltd | Thiazolidine derivative |
| JPS5728075A (en) * | 1980-07-29 | 1982-02-15 | Takeda Chem Ind Ltd | Thiazolidine derivative |
| JPS5728073A (en) * | 1980-07-29 | 1982-02-15 | Takeda Chem Ind Ltd | Inhibitor for aldose reducing enzyme |
| JPS57123175A (en) * | 1981-01-26 | 1982-07-31 | Takeda Chem Ind Ltd | Preparation of thiazolidine derivative |
-
1984
- 1984-01-11 DE DE8484300155T patent/DE3479419D1/de not_active Expired
- 1984-01-11 AT AT84300155T patent/ATE45574T1/de active
- 1984-01-11 EP EP84300155A patent/EP0117035B1/en not_active Expired
- 1984-01-12 GR GR73500A patent/GR79763B/el unknown
- 1984-01-13 CA CA000445291A patent/CA1233470A/en not_active Expired
- 1984-01-13 GT GT198400006A patent/GT198400006A/es unknown
- 1984-01-13 PT PT77958A patent/PT77958B/pt unknown
- 1984-01-16 ES ES528887A patent/ES528887A0/es active Granted
- 1984-01-16 IE IE79/84A patent/IE56842B1/en not_active IP Right Cessation
- 1984-01-16 DK DK17984A patent/DK17984A/da not_active Application Discontinuation
- 1984-01-16 FI FI840155A patent/FI840155A/fi not_active Application Discontinuation
- 1984-01-16 ZA ZA84305A patent/ZA84305B/xx unknown
- 1984-01-16 SU SU843692005A patent/SU1189341A3/ru active
- 1984-01-16 AU AU23287/84A patent/AU539921B2/en not_active Ceased
- 1984-01-16 KR KR1019840000150A patent/KR870001267B1/ko not_active IP Right Cessation
- 1984-01-16 NO NO840144A patent/NO162462C/no unknown
- 1984-01-16 NZ NZ206845A patent/NZ206845A/en unknown
- 1984-01-16 HU HU84149A patent/HU191265B/hu unknown
- 1984-01-16 PL PL1984245745A patent/PL142152B1/pl unknown
- 1984-01-16 DD DD84259419A patent/DD216012A5/de unknown
- 1984-01-16 IL IL70690A patent/IL70690A/xx unknown
- 1984-01-16 YU YU61/84A patent/YU43336B/xx unknown
- 1984-01-17 EG EG32/84A patent/EG16563A/xx active
- 1984-01-17 CS CS84385A patent/CS241149B2/cs unknown
- 1984-01-17 JP JP59006217A patent/JPS59137474A/ja active Granted
- 1984-01-17 PH PH30115A patent/PH18882A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE791592L (en) | Spiro-oxazole derivatives | |
| AU7404791A (en) | Treatment of cataract with 15-keto-prostaglandin compounds | |
| AU1492795A (en) | Retroviral protease inhibiting compounds | |
| JPS56127379A (en) | Hydantoin amine compound | |
| IE791540L (en) | Spiro-furanohydantoin derivatives | |
| EG16563A (en) | Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones | |
| CA2030346A1 (en) | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds | |
| EP0430552A3 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
| IE832854L (en) | Spiro-3-hetero-azolones for treatment of diabetic¹complications. | |
| AU7935887A (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
| ES8504144A1 (es) | Un procedimiento para la preparacion de una 5-(2-alcoxi-fenil 3-sustituido)hidantoina | |
| DE3467166D1 (en) | Spiro-succinimides for treatment of diabetes complications | |
| ES8507119A1 (es) | Procedimiento para la preparacion de un compuesto de 5-(fenil sustituido) hidantoina. | |
| DK0534655T3 (da) | Thiazolidin-2,4-dioner til behandling af hypertension | |
| DK495285A (da) | Spiro-heteroazolon-forbindelser og farmaceutiske praeparater |